Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET
Company Participants
Karina Calzadilla – Head of Investor Relations & FP&A
Chad Robins – Chief Executive Officer & Co-Founder
Kyle Piskel – Chief Financial Officer
Susan Bobulsky – Chief Commercial Officer
Conference Call Participants
Mark Massaro – BTIG
David Westenberg – Piper Sandler
Yuko Oku – Morgan Stanley
Sebastian Sandler – JPMorgan
Tom Stevens – TD Cowen
Corey Rosenbaum – Scotia Bank
Maggie Boeye – William Blair
Operator
Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your first speaker today, Karina Calzadilla, Head of Investor Relations. Please go ahead.
Karina Calzadilla
Thank you, Anton, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnology’s first quarter 2025 earnings conference call. Earlier today, we issued a press release reporting Adaptive financial results for the first quarter of 2025. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the Investors section in our corporate website.
During the call, management will make projections and other forward looking statements within the meaning of federal securities laws regarding future events and the future financial performance of the company. These statements reflect management’s current perspective of the business as of today.
Actual results may differ materially from today’s forward looking statements depending on a number of factors, which are set forth in our public filings with the
#Adaptive #Biotechnologies #Corporation #ADPT #Earnings #Call #Transcript